Maria Velkova

Maria is Managing Partner of Tabula Rasa Ventures, an acceleration fund focused on the blind spots of the healthcare industry, starting with psychedelic therapeutics. Maria was recently named top 15 Global Psychedelics Executives by Business Insider and she is a Board Member of Benzinga Psychedelics Advisory Council. In May 2022, she co-founded the first-ever Medical Psychedelics House of Davos and in January 2023 her and her team led the Davos House of Health alongside the World Economic Forum. Maria also founded Biogenesis Ventures in 2020, an advisory practice focusing on strategy and management consulting for start-ups, early growth stage, and investment companies in the biotechnology and healthcare space. Maria is a seasoned biopharma executive with 10+ years of experience developing and implementing global drug strategy for top pharma companies like Roche, AstraZeneca, Novartis and more. Her expertise bridges the silos in drug development and spans across R&D, clinical trial design, product launch, regulatory affairs, business intelligence, sales, operations and M&A. Maria holds a degree in BSc Pharmacology from Leeds University and MPhil in Bioscience Enterprise from Cambridge University, where she was a visiting lecturer in 2016.